Adderall vs Vyvanse: side by side

Both are amphetamines, both work, the differences are real but not enormous, and the right answer for any given patient depends on factors that the rep…

Sections

1. The basic comparison
2. Why the prodrug thing matters in plain language
3. The l-amphetamine question, which is more interesting than it sounds
4. The smoothness question
5. The duration question
6. The cost and supply question
7. When to start with which
8. Side effects, head to head
9. The cardiac piece, again, because it matters
10. What’s nice to hear, because this is a drug class that mostly works
11. The pattern that ends up switching
12. What not to do
13. Bottom line
14. Sources

Both are amphetamines, both work, the differences are real but not enormous, and the right answer for any given patient depends on factors that the rep who bought your prescriber lunch this week was definitely not going to bring up. Here’s the actual comparison without the marketing layer.

Quick note up top, because anything stimulant-related has to start here: nobody should be starting either of these without a real conversation about the cardiac piece. Not no-risk. The first-time-stimulant-at-fifty conversation is genuinely fraught, anyone on multiple cardiac meds is an iffy candidate at best, and any prescriber who tells you stimulants are completely safe in patients with heart conditions is a damn liar. We’re going to get into the side effects further down but the cardiovascular thing is the one nobody should be glossing over up front.

The basic comparison

Feature	Adderall (XR)	Vyvanse
Active drug	Mixed amphetamine salts (75% d-amphetamine, 25% l-amphetamine)	Lisdexamfetamine, which is just d-amphetamine with a lysine amino acid stuck on it
Duration	8-12 hours	10-14 hours
Onset	30-60 minutes	60-120 minutes
Peak	Sharper, more defined	Smoother, more rounded
End-of-day comedown	More noticeable	Gentler
Abuse potential	Higher (crushable, immediate)	Lower (the conversion is the gate)
Generic available	Yes, since 2009	Yes, since 2023
Cost with generic	Lower	Moderate, dropping
Shortage exposure	Higher	Lower
Standard dose range	10-30 mg XR daily	30-70 mg daily

Why the prodrug thing matters in plain language

Vyvanse is just d-amphetamine with a lysine (which is an amino acid, the building blocks of protein) chemically attached to it, which makes the whole thing inactive until your red blood cells slowly snip the lysine off and release the amphetamine. The snipping happens at a fairly steady rate regardless of stomach pH, food, hydration, or how you took the dose. The result is a smoother onset, a more predictable peak, and less day-to-day variation in how the drug hits you.

The lower abuse potential falls out of the same chemistry. Crushing the pill and snorting it doesn’t do anything useful because the d-amphetamine isn’t free yet, the enzymatic conversion still has to happen first. The pharmaceutical equivalent of locking the activation inside the body’s own enzymatic process, which is harder to defeat than a normal extended-release coating.

Adderall XR by contrast is a mix of two slightly different forms of amphetamine in beads with two different release profiles (immediate and delayed-release). The release profile depends partly on stomach pH and how fast your gut is moving, which means food, hydration, and the rest of the GI environment can shift how the drug hits on any given day. Same dose can feel different on different days, which is part of why some patients find it less consistent than Vyvanse.

The l-amphetamine question, which is more interesting than it sounds

Adderall has both d-amphetamine and l-amphetamine. Vyvanse is pure d-amphetamine. The l-amphetamine in Adderall has slightly different pharmacology (less central, more peripheral, meaning more of the cardiovascular and physical-stimulant effects relative to the focus benefit). For some patients the l-amphetamine piece contributes to the side effects (jitter, racing heart, anxious feeling) without contributing proportionally to the actual focus benefit, and those patients tend to feel cleaner on a pure d-amphetamine drug like Vyvanse or Dexedrine.

For other patients the l-amphetamine piece does something useful, some guys describe a kind of edge or alertness from Adderall that they don’t get from Vyvanse, and those guys prefer Adderall. There’s no test that predicts which kind of patient you are in advance. We just try and see, which is how most of the medication-matching process actually works, despite how it gets described.

The smoothness question

The most consistent thing patients tell me about the difference is that Vyvanse feels smoother. The onset is gentler, the peak is less defined, the comedown at the end of the day isn’t a cliff. Some guys find that a feature, less of a sense of being “on” something, more of a steady background effect. Other guys find it a bug, they want a more defined window so they can plan their day around when the drug is most active.

Adderall has a more defined window. Onset is faster, peak is more pronounced, the end-of-day comedown is more noticeable. For some patients that’s exactly what they want, particularly people working short shifts or hyper-focused task blocks where they want a clear on-off pattern. For other patients the more pronounced peaks and troughs are uncomfortable in a way that takes them a while to articulate.

The duration question

Vyvanse runs longer, ten to fourteen hours for most people, sometimes more. For guys with long workdays (paramedics, contractors, anybody running a kid-pickup schedule on top of an eight-hour office day), the longer duration is a real practical benefit. The catch is that taking Vyvanse too late in the morning will keep you up at night, so most people take it on waking, usually somewhere between five and seven AM.

Adderall XR runs eight to twelve hours. For a standard nine-to-five day starting at seven AM, Adderall XR has mostly cleared by evening, which is fine for most patients and ideal for the sleep-sensitive ones who are going to lie awake at midnight if a stimulant is still onboard.

The cost and supply question

Generic Adderall XR has been around since 2009 and is generally cheap. Generic Vyvanse has been around since 2023 and is now in reasonable cost territory, though typically still more expensive than generic Adderall. For uninsured patients or patients with high deductibles, Adderall has been the more affordable choice for a long time.

Supply is a different story. The Adderall shortage has been ongoing for three-plus years, and while it’s improving (see the DEA quota post for that whole grim conversation), Adderall has been the harder-to-fill stimulant for most of that period. Vyvanse has had occasional shortage hiccups but has been more reliably available. In 2026, the supply factor is a small but real reason to lean Vyvanse for new starts, which is another tick in the Vyvanse-is-better column for prescriptions that haven’t started yet.

When to start with which

Most of my new ADHD starts go on Vyvanse, for practical reasons mostly… smoother onset, more predictable response, better supply, lower abuse potential. The trade-off is the slightly higher cost, which for insured patients in 2026 is usually small enough to ignore.

People I start on Adderall instead are usually patients where cost is a real issue, patients who specifically want a more defined window, patients whose schedule benefits from a shorter duration, and patients who tried Vyvanse and didn’t respond well. First-line isn’t absolute. Both drugs have a place. The choice isn’t ideological, it’s practical, and a prescriber who only ever writes one of them is being a little weird about it.

Switching between them is straightforward. The rough conversion is 20 mg of Adderall XR is roughly equivalent to 50 to 60 mg of Vyvanse, though individual response varies enough that we adjust based on what’s actually happening.

Side effects, head to head

The profile is similar because both drugs are amphetamines. Appetite suppression, dry mouth, mild blood pressure bump, sleep disruption if dosed too late, sometimes jitter or anxious feeling, sometimes end-of-day irritability when the comedown hits.

Adderall, with its sharper peak, tends to produce more pronounced peripheral effects at peak (heart rate, sweating, jitter) for the same effective dose. Vyvanse, with its smoother profile, tends to produce these effects more diffusely but at lower peak intensity. Patients sensitive to peak effects tend to prefer Vyvanse. Patients who don’t notice peaks don’t have a strong preference.

End-of-day comedown is more noticeable on Adderall, partly because the drug drops off faster, partly because the dopamine receptors are returning to baseline after the bigger peak. Some guys describe the Adderall comedown as a brief late-afternoon window of irritability or fatigue, which their kids notice first and their wives notice second. Vyvanse’s comedown is gentler and most patients don’t really feel it as a distinct thing.

The cardiac piece, again, because it matters

Stimulants raise heart rate and blood pressure a bit, that’s just what they do. In a healthy young adult that bump is clinically trivial. In a guy with a cardiac history, uncontrolled hypertension, a known arrhythmia, or a family history of sudden cardiac events, that bump is meaningful and the risk-benefit conversation is real. Same goes for the fifty-year-old starting his first stimulant trial, which is a different conversation than the same drug for a twenty-five-year-old.

The right workup before starting either Adderall or Vyvanse includes a real cardiovascular history (chest pain, palpitations, syncope, exercise tolerance, family history of sudden death under fifty), a baseline blood pressure check, and a referral for an EKG and possibly cardiology clearance if any of those flags are present. Skipping this because the patient is “young and healthy” is the move you regret about once a career. Don’t be the prescriber who skips it, and if you’re the patient, don’t go to a clinic that doesn’t ask.

What’s nice to hear, because this is a drug class that mostly works

For the patient who actually has ADHD and gets matched to a stimulant that fits their schedule and their physiology, this stuff genuinely works, often the day you take it. People come back at the two-week visit and the conversation is some version of, oh, this is what other people’s brains feel like? The mornings stop being a war, the kid’s homework gets done without three reminders, the half-finished projects on the garage workbench start finishing. That’s a real outcome, and articulating the relief is part of the honest version of this conversation, not just the side-effect ledger.

Personal disclosure: Vyvanse is my own favorite of the two, and I’m on it myself. That doesn’t make it the right answer for everybody, but it’s the honest answer about where I land when somebody asks me what I’d start with for a new patient.

The pattern that ends up switching

The kind of guy who comes in for a Vyvanse switch is the one who started on Adderall XR a year ago because his insurance favored it, did fine for a while, and then started complaining that the afternoon comedown was making him snappy with his kids around five PM. His wife noticed it before he did. We switch him to Vyvanse 50 mg, the smoother profile suits him better, the focus benefit is the same, the peak side effects are less, and the comedown stops being a thing. Three years later he’s still on Vyvanse and his wife says the difference is obvious, which is usually the truest test of whether a switch was the right call.

Same dose can feel different on different days with Adderall. The Vyvanse version doesn’t really do that.

What not to do

Don’t take either of these in the afternoon, the sleep loss will catch up with you. Don’t combine with MAOIs (the older antidepressants where the food-list rules apply, see the depression post for the MAOI digression). Don’t double up if you missed yesterday, the dose-stacking is exactly how the cardiovascular side effects get serious. Don’t switch between them on your own without talking to your prescriber, the conversions are roughly known but the individual variability is real.

Bottom line

Both are amphetamines, both work, the differences are real but not huge. Vyvanse is smoother, longer, and harder to abuse. Adderall is cheaper, has a more defined window, and has been more shortage-affected. For most new starts in 2026 I lean Vyvanse, for patients already doing well on Adderall there’s no good reason to switch, and the best stimulant for any individual patient is the one that works for that patient, which is figured out by trying and not by reading articles like this one. But you read the article anyway. The internet is a hell of a thing.

Sources

1. Stuhec M, Lukic P, Locatelli I. Efficacy, Acceptability, and Tolerability of Lisdexamfetamine, Mixed Amphetamine Salts, Methylphenidate, and Modafinil in the Treatment of Attention-Deficit Hyperactivity Disorder in Adults: A Systematic Review and Meta-analysis. Ann Pharmacother. 2019;53(2):121-133. PMID 30117329.
2. Cortese S, Adamo N, Del Giovane C, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727-738. PMID 30097390.
3. Zhang L, Yao H, Li L, et al. Risk of Cardiovascular Diseases Associated With Medications Used in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022;5(11):e2243597. PMID 36416824.
4. Sheykhsoltan M, Drobina J, Burns MM, Fox ER, Mazer-Amirshahi M. Drug Shortages for Prescription Amphetamine Derivatives. J Pediatr Pharmacol Ther. 2025;30(2):206-211. PMID 40717757.